文献速递生殖医学产科母胎医学

胚胎玻璃化冷冻对单胎活产胎盘组织病理学特征及围产结局的影响

The impact of embryo vitrification on placental histopathology features and perinatal outcome in singleton live births.
PubMed 文献 · Hum Reprod · 2022-01-01

该回顾性队列研究纳入2009至2017年单家学术三级医院经自体卵母细胞IVF治疗后的1014例单胎活产,比较激素替代玻璃化冷冻胚胎移植(n=354)与新鲜胚胎移植(n=660)的胎盘病理及围产结局。多因素校正后,冷冻胚胎移植与绒毛膜羊膜炎伴母体及胎儿反应、胎儿血管灌注不良、分叉脐带插入、不明原因绒毛炎、绒毛间血栓、绒毛膜下血栓及产程进展失败显著相关。

要点

  • 冷冻胚胎移植与绒毛膜羊膜炎伴母体反应(OR 2.0;95%CI 1.2-3.3)及胎儿反应(OR 2.6;95%CI 1.2-5.7)相关。
  • 冷冻胚胎移植与胎儿血管灌注不良(OR 3.9;95%CI 1.4-9.2)及分叉脐带插入(OR 2.3;95%CI 1.2-5.3)相关。
  • 冷冻胚胎移植与产程进展失败相关(OR 2.5;95%CI 1.5-4.2)。

核心结论

  • 胚胎玻璃化冷冻对胎盘组织病理学模式有显著影响,并与产程进展失败(功能失调性产程)患病率较高相关。

研究设计与样本

  • 回顾性队列研究,纳入2009至2017年单家学术三级医院经自体卵母细胞IVF治疗后的所有活产,最终分析1014例单胎活产,新鲜胚胎移植组n=660,激素替代冷冻胚胎移植组n=354。
  • 所有患者胎盘均送病理评估,不论母体或胎儿并发症状态;采用多因素分析校正与胎盘组织病理学异常发展可能相关的决定因素。

主要发现

  • 校正混杂因素后,冷冻胚胎移植与绒毛膜羊膜炎伴母体反应显著相关(OR 2.0;95%CI 1.2-3.3),与绒毛膜羊膜炎伴胎儿反应显著相关(OR 2.6;95%CI 1.2-5.7)。
  • 冷冻胚胎移植与胎儿血管灌注不良显著相关(OR 3.9;95%CI 1.4-9.2),与分叉脐带插入显著相关(OR 2.3;95%CI 1.2-5.3)。
  • 冷冻胚胎移植与不明原因绒毛炎显著相关(OR 2.1;95%CI 1.1-4.2),与绒毛间血栓显著相关(OR 2.1;95%CI 1.3-3.7),与绒毛膜下血栓显著相关(OR 3.4;95%CI 1.6-7.0)。
  • 冷冻胚胎移植与产程进展失败显著相关(OR 2.5;95%CI 1.5-4.2)。

关键数值与推荐

  • 新鲜胚胎移植组n=660,激素替代冷冻胚胎移植组n=354,共1014例单胎活产纳入最终分析。
  • 绒毛膜羊膜炎伴母体反应:OR 2.0;95%CI 1.2-3.3;伴胎儿反应:OR 2.6;95%CI 1.2-5.7。
  • 胎儿血管灌注不良:OR 3.9;95%CI 1.4-9.2;分叉脐带插入:OR 2.3;95%CI 1.2-5.3。
  • 不明原因绒毛炎:OR 2.1;95%CI 1.1-4.2;绒毛间血栓:OR 2.1;95%CI 1.3-3.7;绒毛膜下血栓:OR 3.4;95%CI 1.6-7.0。
  • 产程进展失败:OR 2.5;95%CI 1.5-4.2。

临床怎么用

  • 作者认为研究结果有助于理解新鲜与玻璃化冷冻胚胎的围产结局,其发现可能对选择新鲜或冷冻复苏胚胎移植的临床决策有启示。

局限性

  • 冷冻复苏胚胎活产组包含既往胚胎移植失败的治疗周期,影响胚胎玻璃化冷冻的因素可能影响种植与胎盘组织病理学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does embryo vitrification affect placental histopathology pattern and perinatal outcome in singleton live births? SUMMARY ANSWER: Embryo vitrification has a significant effect on the placental histopathology pattern and is associated with a higher prevalence of dysfunctional labor. WHAT IS KNOWN ALREADY: Obstetrical and perinatal outcomes differ between live births resulting from fresh and frozen embryo transfers. The effect of embryo vitrification on the placental histopathology features associated with the development of perinatal complications remains unclear. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study evaluating data of all live births from one academic tertiary hospital resulting from IVF treatment with autologous oocytes during the period from 2009 to 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: All patients had placentas sent for pathological evaluation irrelevant of maternal or fetal complications status. Placental, obstetric and perinatal outcomes of pregnancies resulting from hormone replacement vitrified embryo transfers were compared with those after fresh embryo transfers. A multivariate analysis was conducted to adjust the results for determinants potentially associated with the development of placental histopathology abnormalities. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 1014 singleton live births were included in the final analysis and were allocated to the group of pregnancies resulting from fresh (n = 660) and hormone replacement frozen (n = 354) embryo transfers. After the adjustment for confounding factors the frozen embryo transfers were found to be significantly associated with chorioamnionitis with maternal (odds ratio (OR) 2.0; 95% CI 1.2-3.3) and fetal response (OR 2.6; 95% CI 1.2-5.7), fetal vascular malperfusion (OR 3.9; 95% CI 1.4-9.2), furcate cord insertion (OR 2.3 95% CI 1.2-5.3), villitis of unknown etiology (OR 2.1; 95% CI 1.1-4.2), intervillous thrombi (OR 2.1; 95% CI 1.3-3.7), subchorionic thrombi (OR 3.4; 95% CI 1.6-7.0), as well as with failure of labor progress (OR 2.5; 95% CI 1.5-4.2). LIMITATIONS, REASONS FOR CAUTION: Since the live births resulted from frozen-thawed embryos included treatment cycles with previously failed embryo transfers, the factors over embryo vitrification may affect implantation and placental histopathology. WIDER IMPLICATIONS OF THE FINDINGS: The study results contribute to the understanding of the perinatal future of fresh and vitrified embryos. Our findings may have an implication for the clinical decision to perform fresh or frozen-thawed embryo transfer. STUDY FUNDING/COMPETING INTEREST(S): Authors have not received any funding to support this study. There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Volodarsky-Perel A, Ton Nu TN, Orvieto R, et al. The impact of embryo vitrification on placental histopathology features and perinatal outcome in singleton live births. Hum Reprod. 2022. PMID: 35906920. doi:10.1093/humrep/deac167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。